Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SARS (severe acute respiratory syndrome) diagnosis and patenting, a story of two wars

This article was originally published in Clinica

Executive Summary

Prompt diagnosis has emerged as the key priority of the war against severe acute respiratory syndrome (SARS), after mortality from the disease in China has soared to three times the World Health Organization's upgraded global rate of 7%. Meanwhile, manufacturers and public health bodies alike have become embroiled in a battle of their own to secure patenting rights over the virus.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT062055

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel